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esponsibility of InstAbstract Multi-component ﬁngerprinting and quantitation of the glucosinolates and nucleosides in samples
of Radix Isatidis have been carried out using high-performance liquid chromatography with diode-array
detection and electrospray ionization tandem mass spectrometry (HPLC–DAD–ESI/MS). Five nucleosides
together with one glucosinolate were identiﬁed by comparing retention times, ultraviolet spectra, mass spectra
and/or empirical molecular formulae of reference compounds. Quantitation of these six compounds was carried
out simultaneously by HPLC on a Phenomenex Luna C18 column using gradient elution with methanol and
water and detection at 254 nm. All calibration curves were linear (r40.9994) within test ranges. Limits of
detection and quantitation were 0.33 ng and 2.50 ng on column, respectively. Intra- and inter-day precision (as
relative standard deviation) for all analytes was o2.19% with recoveries in the range 99.6%–101.8% at three
concentration levels. The validated method was successfully applied to ﬁngerprinting and assay of 25 batches
of Radix Isatidis sourced from different geographical regions of China. The method is simple and reliable and
has potential value in the quality control of Radix Isatidis.
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X. Wang et al.3381. Introduction
Radix Isatidis (Banlangen or Bei-Banlangen in Chinese) is a
traditional Chinese medicine (TCM) consisting of the dried root of
Isatis indigotica Fort (Cruciferae). It was ﬁrst recorded in Shen
Nong's Herbal classic and has been used in China as an antipyretic
and detoxifying herb for over 2000 years1,2. Like many TCM,
Radix Isatidis displays diverse pharmacological activities and
exerts antibacterial3–5, antiviral6–10, antiinﬂammatory11,12, antitu-
mor13,14, antiendotoxic15–23 and immune regulatory effects24–26. In
fact, these effects have translated into pronounced clinical success
in the treatment and/or prevention of inﬂuenza, tonsillitis and
malignant infectious diseases27–30 particularly severe acute respira-
tory syndrome (SARS) and H1N1-inﬂuenza31–33. It is now an
established component of many TCM preparations such as
Banlangen Granules and Qingkailing Injection which is widely
used as antipyretic and antiviral drug in clinical practice.
The potent antiviral activity of Radix Isatidis is attributed to the
presence of nucleosides which interfere in the gene expression of
virus and thereby inhibit their proliferation and protect cells from
virus damage34. As a result, some water soluble compounds
including glucosinolates (R,S-goitrin, progoitrin, epiprogoitrin
and gluconapin) and nucleosides (hypoxanthine, adenosine, uri-
dine and guanosine) have been investigated as potential indicators
of the quality of Radix Isatidis and its ﬁnished products rather than
non-polar components such as indigotin and indirubin35–40.
Recently, holistic chemical proﬁling of Radix Isatidis has been
developed using HPLC41,42 to determine eight bioactive constitu-
ents, including 5 glucosinolates and 3 nucleosides43.
In this paper, a powerful strategy incorporating chemical
ﬁngerprinting and simultaneous quantitation has been developed
for the quality assessment of Radix Isatidis. The method involving
HPLC coupled with diode-array detection and electrospray ioniza-
tion tandem mass spectrometry (HPLC–DAD–ESI/MS) was
applied to evaluate the holistic qualities of commercially available
Radix Isatidis from the herbal market in China. Chemical
ﬁngerprints based on the detection and simultaneous assay of ﬁve
nucleosides and one glucosinolate were subjected to similarity
analysis and partial least squares discrimination analysis (PLS-DA)
to evaluate the technique. The validated method is expected to
offer a more effective strategy to ensure consistent quality of
Radix Isatidis.2. Materials and methods
2.1. Chemicals, reagents and plant materials
Reference standards (batch numbers) and suppliers were as
follows: uridine (887-200001), adenine (886-200001) and adeno-
sine (110879-200202), National Institute for Food and Drug
Control (Beijing, China); cytidine (200-610-9) and guanosine
(G6752), Sigma-Aldrich (St. Louis, M.O., USA); R,S-goitrin
(101103), Sichuan Victory Pharmaceutical Co., Ltd. (Chengdu,
China). All standards were biochemical reagent grade (puritiesZ98%)
as conﬁrmed by HPLC.
HPLC-grade methanol was obtained from J.T. Baker. Ultrapure
water (18.2 mΩ) daily prepared with a Milli-Q water puriﬁcation
system (Millipore, Molsheim, France) was used in the mobile
phase. Other reagents were of analytical grade and used as
received.Twenty-ﬁve batches of Radix Isatidis from different geographi-
cal regions around China were obtained from three pharmaceutical
companies producing the same TCM preparations using Radix
Isatidis as raw material. All samples were morphologically
authenticated by the authors and voucher specimens were depos-
ited with the Department of Chemistry, Tsinghua University,
Beijing, China.
2.2. Sample preparation
The root of Isatis indigotica Fort. were pulverized and approxi-
mately 0.5 g of ground sample accurately weighed and extracted
by ultrasonication (44 kHz, 250 W) with 5 mL water for 20 min at
room temperature. The extracts were then ﬁltered through 0.2 μm
PTFE syringe ﬁlters and 10 μL of each ﬁltrate subjected to HPLC–
DAD–ESI/MS analysis. Stock solutions (ca. 1.0 mg/mL) of the six
reference compounds viz uridine, adenine, adenosine, cytidine,
guanosine and R,S-goitrin were prepared in 50% methanol and
stored at 4 1C until required. Equal volumes of these six stock
solutions were mixed and diluted with 50% methanol to obtain a
series of seven mixed standard solutions. The mixed standards
were ﬁltered through 0.2 μm PTFE syringe ﬁlters and 10 μL
injected into the HPLC system.
2.3. HPLC–DAD analysis
HPLC was performed on an Agilent 1200 series system (Agilent
Series 1200, Palo Alto, CA, USA) consisting of a binary pump,
autosampler and diode array detector. After scanning in the range
200–400 nm, a wavelength of 254 nm was selected for qualitative
and quantitative analysis. Chromatography was performed on a
Phenomenex Luna C18 analytical column (250 mm 4.6 mm,
5 μm) at 25 1C using gradient elution at 0.8 mL/min of (A) water
and (B) methanol according to the following program: 0–10 min
5% B; 10–25 min 5–15% B; 25–34 min 15–35% B; 34–40 min
35–95% B. The column was re-equilibrated for 10 min between
individual runs.
2.4. Mass spectrometry
Accurate mass determination to generate empirical formulae was
performed on an Agilent 1100 Series LC/MSD TOF (Agilent
Technologies Corp., Santa Clara, CA, USA) using electrospray
ionization (ESI) in both positive (ESIþ) and negative (ESI) ion
modes. HPLC efﬂuent was introduced into the mass spectrometer
with a post-column split of 3:1. Optimized ESI-MS parameters
were: capillary voltage 3500 V (ESI) or 4000 V (ESIþ); drying
gas 8.0 L/min; nebulizer pressure 40 psi; gas temperature 325 1C;
fragmentor voltage 175 V (ESIþ) and 190 V (ESI); skimmer
voltage 60 V; octopole dcl 37.5 V (ESIþ) or 38.0 V (ESI);
octopole RF 250 V. Full-scan mass spectra were recorded in the
range m/z 50–1500. Continuous calibration was maintained using
reference masses of m/z 121.0509 and 922.0098. Analyst QS
software (Applied Biosystems, Framingham, MA) was used to
process mass data and to generate exact masses corresponding to
particular elemental compositions. Instrument tuning was carried
out daily using the tuning solution (G1969-85000, Agilent Corp,
USA) to ensure a mass error o5 ppm prior to sample analysis.
Fragmentation data for structure conﬁrmation was generated on
an Agilent 1100 Series HPLC instrument coupled to a 6300 series
ion trap (G2445A, Agilent Technologies, Santa Clara, USA) via an
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capillary voltage 3500 V (ESI) or 4000 V (ESIþ); skimmer
voltage 40 V; capillary exit voltage 137 V; nebulizer pressure
30 psi; drying gas 8 L/min; gas temperature 325 1C; target mass
m/z 622; compound stability 100%; trap drive level 60%; threshold
50,000 (ESIþ) and 10,000 (ESI); ion charged control (ICC) on;
target 10,000; accumulation time 200 ms. The amplitude voltage
was generally 0.6 V for fragmentation in MS3 experiments. Data
was processed by Agilent Chemstation Rev. A. 09.01 software
(Agilent, Palo Alto, CA, USA).2.5. Data analysis
Each sample solution was analyzed in triplicate and concentrations
based on peak areas determined from the appropriate calibration
curve. Identiﬁcation of all marker compounds was based on a
comparison of HPLC retention times, MS fragmentation pattern
and UV spectra of peaks with data for corresponding standards.
Similarity evaluation was performed using the Similarity Evalua-
tion System for Chromatographic Fingerprinting of Traditional
Chinese Medicines (Version 2004A) published by the Chinese
Pharmacopoeia Committee. The software mainly uses the correla-
tion coefﬁcient for evaluating the similarities of different chroma-
tograms44. Partial least squares discrimination analysis (PLS-DA)
was performed using SIMCA-P (version 12.0, Demo).3. Results and discussion
3.1. Optimization of HPLC conditions
Column type, mobile phase composition, gradient elution pro-
gram, ﬂow rate and column temperature were optimized to achieve
maximum resolution in the minimum run time. The detection
wavelength for quantitative analysis was selected as 254 nm at
which all marker components showed absorption. Representative
HPLC chromatograms of Radix Isatidis are shown in Fig. 1.Figure 1 Typical chromatograms of (A) a mixed standard solution and (B
compounds. 1, cytidine; 2, uridine; 3, adenine; 4, guanosine; 5, R,S-goitri3.2. Optimization of extraction method
Considering the analytes of interest are relatively polar, aqueous
methanol was predicted and found to be a suitable extraction
solvent. Extraction conditions including extraction method (reﬂux
or ultrasonication), number of extractions (1, 2 or 3), methanol
concentration (0%, 25%, 50%, 75% and 100% v/v) and extraction
time (20, 40 and 60 min) were investigated to give the maximum
number of peaks in the HPLC ﬁngerprint. Finally, the extraction
method presented in Section 2.2 was selected.3.3. Identiﬁcation of marker compounds
HPLC-UV and LC–ESI/MS analysis of the aqueous extract of
Radix Isatidis (Sample 1) showed six peaks (Fig. 1) which were
characterized by the online UV spectra. These showed maximum
absorption at 260–270 nm for nucleosides and 245–252 nm for the
glucosinolate. By comparing retention times, UV spectra, m/z of
characteristic molecular ions, empirical molecular formulae and
low-energy collision induced dissociation fragment ions with those
produced by authentic standards, the compounds corresponding to
Peaks 1–6 were identiﬁed as cytidine, uridine, adenine, guanosine,
R,S-goitrin and adenosine, respectively. The characteristics of
these six compounds are given in Table 1 which shows that mass
accuracy for all molecular ions, quasi-molecular ions and fragment
ions was o30 ppm. This indicates that the empirical molecular
formulae were well matched to the putative deprotonated ions,
quasi-molecular ions and fragment ions.3.4. Assay validation for quantitation
The quantitative HPLC method was validated by deﬁning linearity,
limit of quantitation (LLOQ) and limit of detection (LOD), repeat-
ability, accuracy and precision and stability. Linearity was assessed
by linear regression of calibration curves for each analyte. The
regression equations, correlation coefﬁcients and linear ranges for six
marker compounds are shown in Table 2. The LOD and LLOQ,
calculated as the concentrations giving signal-to-noise ratios of 3 (S/
N¼3) and 10 (S/N¼10) respectively, are also listed in Table 2.) an aqueous extract of Radix Isatidis showing peaks from six bioactive
n; 6, adenosine.
Table 2 Calibration curves and detection limits (LOD and LLOQ) for the six marker compounds in Radix Isatidis.
Compound Calibration curvea r Linear range (mg/mL) LODb(ng) LLOQb(ng)
Cytidine (1) Y¼19573Xþ2.5872 0.9998 3.4 10–3–11.0 10–2 0.34 1.13
Uridine (2) Y¼24259Xþ41.870 0.9994 4.7 10–3–15.0 10–2 0.44 1.47
Adenine (3) Y¼65688X19.286 0.9998 1.7 10–3–5.33 10–2 0.56 1.88
Guanosine (4) Y¼32675X7.3438 0.9998 4.3 10–3–13.6 10–2 0.34 1.15
R,S-Goitrin (5) Y¼26506X571.99 0.9996 23.7 10–3–75.5 10–2 0.75 2.50
Adenosine (6) Y¼39284X4.1087 1.000 2.4 10–3–7.71 10–2 0.33 1.09
aY is peak area; X is concentration (mg/mL) of analytes.
bThe LOD and LLOQ are deﬁned as the concentrations that can be detected at S/N ratios of 3 and 10 respectively.
Table 3 Accuracy of HPLC-UV method for the determination of six marker compounds.
Compound Original (μg) Spiked (μg) Found (μg) Recovery (%) RSD (%)
Cytidine (1) 5.98 4.79 10.76 101.25 1.77
5.62 11.73
7.36 13.47
Uridine (2) 9.76 7.32 17.16 101.53 1.59
9.56 19.47
11.91 21.89
Adenine (3) 5.49 4.50 10.13 100.95 2.97
5.76 11.13
6.48 12.07
Guanosine (4) 5.80 4.52 10.28 99.81 2.94
5.60 11.52
6.96 12.61
R,S-Goitrin (5) 58.97 45.41 103.99 99.30 1.24
61.92 120.66
70.18 128.54
Adenosine (6) 2.99 2.33 5.33 98.98 2.98
3.23 6.11
3.68 6.65
Table 1 Components identiﬁed in samples of Radix Isatidis.
Compound
No.
tR
(min)
Identiﬁcationa UV
(λmax,
nm)
MS
Selected
ion
Formula Measured
mass
Calculated
mass
Mass
accuracy
(ppm)
MS (pos/neg ionization)
MS (m/
z)
MS2 (m/z)
1 8.3 Cytidine 236
(sh),
270
[MþH]þ C9H14N3O5 244.0925 244.0927 1.2175 242.8
[MH]
199.7
[MHHNCO]
2 13.5 Uridine 260 [MH] C9H11N2O6 243.0672 243.0611 24.8378 242.9
[MH]
199.9
[MHHNCO]
3 21.0 Adenine 260 [MþH]þ C5H6N5 136.0625 136.0617 5.3526 136.0
[MþH]þ
4 25.0 Guanosine 250,
280
(sh)
[MþH]þ C10H14N5O5 284.0982 284.1046 2.6231 281.9
[MH]
194.8
[MHC2N3HO]
5 28.1 R,S-Goitrin 245 [MþH]þ C5H7NOS 130.0340 130.0151 14.5177 130.0
[MþH]þ
6 33.6 Adenosine 260 [MþH]þ C10H14N5O4 268.1089 268.1040 2.1238 268.1
[MþH]þ
136.0
[MC4H4O3]þ
aCompared with authentic compounds.
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replicate extracts of a powdered Radix Isatidis sample on one day
and assay of the same six extracts on three separate days
respectively. Intra- and inter-day precision (as relative standard
deviation RSD) were found to be o0.76% and o2.19%,
respectively. Accuracy (recovery) was determined by assay of an
extract spiked in triplicate with low, medium and high concentra-
tions of the mixed standard solution. Accuracy was found to be in
the range 98.6%–101.5% with an RSD of 1.24%–2.98% (Table 3).
Stability was assessed by measuring peak areas of the six
compounds initially and after 4, 8, 12, 16 and 24 h at room
temperature. Variation in peak area of the six compounds was
o3.0%. These results indicate that the HPLC method is precise,
accurate and sensitive for quantitative determination of the nucleo-
sides and glucosinolates in Radix Isatidis samples.Figure 3 Similarity evaluation of the HPLC ﬁngerprints of 25 Radix
Isatidis samples classiﬁed into three groups (A, B and C) based on the
three pharmaceutical companies from which they were sourced.3.5. Chemical proﬁling and quantitation
Chemical proﬁling and assay of 25 samples of Radix Isatidis
from different geographical regions of China were carried out.
Fig. 2 presents typical HPLC chromatograms of their aqueous
extracts.
The State Food and Drug Administration (SFDA) suggests
that chromatograms of herbal samples should be evaluated in
terms of similarity by calculating the correlation coefﬁcient
and/or angle cosine value of the original data. A representative
ﬁngerprint of Radix Isatidis was generated for all samples
using the software of the Similarity Evaluation System and the
peak from R,S-goitrin as reference. As shown in Fig. 3, all
samples showed average similarity of 0.928. The chemical
constituents in samples from company A (samples 1–10) and B
(samples 11–15) were signiﬁcantly different within groupsFigure 2 HPLC ﬁngerprints of 25 samples of Radix Isatidis and the refe
based on identiﬁcation and quantitation of six compounds. 1, cytidine; 2,with similarities in the ranges 0.729–0.986 and 0.751–0.976,
respectively, while those in samples from company C (samples
16–25) exhibited satisfactory consistency within the group
with a similarity in the range 0.959–0.993. The ﬁngerprints
were also subjected to PLS-DA which showed the samples
from different companies were well separated by PLS-DA with
variability in the contents of the six marker components
(Fig. 4). Thus the results of PLS-DA and similarity analysis
are consistent. In the scatter plot, samples from companies A
and B were more discrete than those of company C (only
sample 25 was shown to be an outlier) suggesting the quality
of the Radix Isatidis samples sourced from company C were
more stable.
The content (mg/g) of the six marker compounds in the 25
samples of Radix Isatidis is shown in Table 4. All samples
contained all six compounds. The content of R,S-goitrin was in
the range 0.36–4.50 mg/g which is higher than the deﬁnedrence standard ﬁngerprint generated by similarity evaluation software
uridine; 3, adenine; 4, guanosine; 5, R,S-goitrin; 6, adenosine.
Figure 4 Discrimination analysis based on a PLS-DA plot of the ﬁngerprints of 25 samples of Radix Isatidis generated by SIMCA-P (version
12.0, Demo). Samples are classiﬁed into three groups (A, B and C) based on the three pharmaceutical companies from which they were sourced.
Table 4 Content (mg/g) of six marker compounds in 25 samples of Radix Isatidis.
Batch no. Sample itemsa Contentb (mg/g)
Cytidine Uridine Adenine Guanosine R,S-Goitrin Adenosine Total
120502 A 0.24 0.27 0.07 0.27 2.82 0.32 3.98
120501 A 0.15 0.31 0.04 0.27 0.67 0.39 1.83
120516 A 0.12 0.29 0.03 0.22 1.20 0.24 2.10
120503 A 0.31 0.34 0.13 0.44 4.50 0.21 5.92
120518 A 0.27 0.42 0.08 0.37 1.28 0.30 2.72
120519 A 0.19 0.28 0.04 0.30 1.28 0.29 2.39
120514 A 0.16 0.23 0.04 0.25 2.32 0.27 3.27
120507 A 0.26 0.42 0.06 0.37 0.36 0.36 1.84
120602 A 0.23 0.35 0.04 0.33 0.65 0.31 1.91
120509 A 0.28 0.36 0.06 0.36 0.68 0.34 2.09
120401 B 0.25 0.51 0.06 0.51 0.52 0.65 2.50
120501 B 0.49 0.70 0.08 0.80 0.57 0.71 3.33
120602 B 0.45 0.67 0.08 0.75 0.59 0.63 3.19
120601 B 0.49 0.71 0.10 0.61 0.73 0.47 3.11
110503 B 0.25 0.35 0.04 0.35 3.93 0.46 5.38
110317 C 0.15 0.29 0.04 0.21 1.35 0.21 2.26
110209 C 0.15 0.30 0.04 0.21 1.43 0.22 2.36
110216 C 0.14 0.28 0.04 0.18 1.56 0.19 2.39
110304 C 0.17 0.31 0.09 0.21 1.90 0.14 2.81
110213 C 0.19 0.32 0.05 0.21 1.61 0.20 2.58
110220 C 0.17 0.32 0.05 0.22 1.98 0.23 2.97
110225 C 0.19 0.34 0.06 0.20 1.64 0.20 2.62
110228 C 0.17 0.30 0.04 0.24 2.69 0.22 3.67
110223 C 0.17 0.30 0.06 0.20 1.78 0.19 2.71
110307 C 0.27 0.39 0.21 0.40 3.23 0.02 4.52
Min 0.12 0.23 0.03 0.18 0.36 0.02 1.83
Max 0.49 0.71 0.21 0.80 4.50 0.71 5.92
Average 0.24 0.37 0.07 0.34 1.65 0.31 2.98
SD (n¼25) 0.10 0.13 0.04 0.17 1.09 0.16 1.04
All samples were morphologically authenticated as Radix Isatidis according to the current standard of the Chinese Pharmacopoeia.
aSample item A, B and C refers to the three pharmaceutical companies from which the samples were sourced.
bValues are in mg/g of dry raw material and expressed as mean7SD, n¼3; the SD was o4%.
X. Wang et al.342limit of 0.2 mg/g set by the Chinese Pharmacopoeia. This
means that all samples qualiﬁed as crude material. However, as
shown in Fig. 5, signiﬁcant differences exist in the content of
the six marker compounds particularly for R,S-goitrin wherethe contents showed an RSD of 66%. Such signiﬁcant
differences in the content of chemical constituents would
likely be associated with variable quality and uncertain
therapeutic efﬁcacy of this herb and the TCM which include it.
Figure 5 Comparison of the average content (mg/g) of the six
marker compounds in 25 samples of Radix Isatidis classiﬁed into three
groups (A, B and C) based on the three pharmaceutical companies
from which they were sourced.
Qualitative and quantitative analysis of glucosinolates and nucleosides in Radix Isatidis 3434. Conclusions
HPLC ﬁngerprint analysis was used to evaluate the quality and
consistency of 25 samples of Radix Isatidis sourced from different
regions of China and used by three pharmaceutical companies to
make various TCM preparation. Fingerprints were based on the
simultaneous identiﬁcation and quantitation of ﬁve nucleosides
and one glucosinolate. Similarity analysis was used to compare the
ﬁngerprints and demonstrate the consistency of the groups of
samples sourced from the three companies. The method was
shown to provide an effective quality evaluation strategy to ensure
the consistent quality of Radix Isatidis.
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